Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.
Research has found that it can take more than six months for professional athletes to return to play after being treated for a deep-vein thrombosis or pulmonary embolism.
One of this year’s most important relationships in global financial markets is falling apart
One of the most important relationships in global markets has started to unravel over the past couple of weeks. Investors are scrambling to figure out what it might mean for the economy, and their portfolios.
‘I’m naturally skeptical’: I receive 10 calls a day offering me $15,000 loans at 8% interest. Is this a scam?
“They insist that the details will be provided after they have carried out a soft credit check.”
Robot factories and hypersonic missiles: JPMorgan Chase’s first $5 billion of defense investments
With $5 billion already deployed off its balance sheet, JPMorgan Chase is racing ahead on direct investments in defense tech, hardware and supply chains.
Stocks are heading for a high-stakes showdown, as strong earnings collide with rising borrowing costs
The idea that the AI trade has been mostly immune to rising bond yields isn’t quite right, one strategist notes.
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Boeing, Meta and EchoStar recorded steep charges and expenses a year ago, which are expected to make this latest quarter’s results look especially strong by comparison.
